• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫系统在三核苷酸重复扩增疾病中的作用。

The role of the immune system in triplet repeat expansion diseases.

作者信息

Olejniczak Marta, Urbanek Martyna O, Krzyzosiak Wlodzimierz J

机构信息

Department of Molecular Biomedicine, Institute of Bioorganic Chemistry, Polish Academy of Sciences, Noskowskiego 12/14, 61-704 Poznan, Poland.

出版信息

Mediators Inflamm. 2015;2015:873860. doi: 10.1155/2015/873860. Epub 2015 Mar 22.

DOI:10.1155/2015/873860
PMID:25873774
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4385693/
Abstract

Trinucleotide repeat expansion disorders (TREDs) are a group of dominantly inherited neurological diseases caused by the expansion of unstable repeats in specific regions of the associated genes. Expansion of CAG repeat tracts in translated regions of the respective genes results in polyglutamine- (polyQ-) rich proteins that form intracellular aggregates that affect numerous cellular activities. Recent evidence suggests the involvement of an RNA toxicity component in polyQ expansion disorders, thus increasing the complexity of the pathogenic processes. Neurodegeneration, accompanied by reactive gliosis and astrocytosis is the common feature of most TREDs, which may suggest involvement of inflammation in pathogenesis. Indeed, a number of immune response markers have been observed in the blood and CNS of patients and mouse models, and the activation of these markers was even observed in the premanifest stage of the disease. Although inflammation is not an initiating factor of TREDs, growing evidence indicates that inflammatory responses involving astrocytes, microglia, and the peripheral immune system may contribute to disease progression. Herein, we review the involvement of the immune system in the pathogenesis of triplet repeat expansion diseases, with particular emphasis on polyglutamine disorders. We also present various therapeutic approaches targeting the dysregulated inflammation pathways in these diseases.

摘要

三核苷酸重复扩增疾病(TREDs)是一组由相关基因特定区域不稳定重复序列扩增引起的显性遗传神经疾病。各基因翻译区域中CAG重复序列的扩增会导致富含聚谷氨酰胺(polyQ)的蛋白质形成,这些蛋白质会形成细胞内聚集体,影响众多细胞活动。最近的证据表明RNA毒性成分参与了聚谷氨酰胺扩增疾病,从而增加了致病过程的复杂性。神经退行性变伴有反应性胶质增生和星形细胞增多是大多数TREDs的共同特征,这可能表明炎症参与了发病机制。事实上,在患者和小鼠模型的血液和中枢神经系统中观察到了许多免疫反应标志物,甚至在疾病的临床前期就观察到了这些标志物的激活。虽然炎症不是TREDs的起始因素,但越来越多的证据表明,涉及星形胶质细胞、小胶质细胞和外周免疫系统的炎症反应可能促进疾病进展。在此,我们综述免疫系统在三联体重复扩增疾病发病机制中的作用,特别强调聚谷氨酰胺疾病。我们还介绍了针对这些疾病中失调的炎症途径的各种治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab34/4385693/40c9b754d1ba/MI2015-873860.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab34/4385693/40c9b754d1ba/MI2015-873860.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab34/4385693/40c9b754d1ba/MI2015-873860.001.jpg

相似文献

1
The role of the immune system in triplet repeat expansion diseases.免疫系统在三核苷酸重复扩增疾病中的作用。
Mediators Inflamm. 2015;2015:873860. doi: 10.1155/2015/873860. Epub 2015 Mar 22.
2
Mechanisms of RNA-induced toxicity in CAG repeat disorders.CAG 重复疾病中 RNA 诱导毒性的机制。
Cell Death Dis. 2013 Aug 1;4(8):e752. doi: 10.1038/cddis.2013.276.
3
Small non-coding RNAs add complexity to the RNA pathogenic mechanisms in trinucleotide repeat expansion diseases.小非编码RNA增加了三核苷酸重复扩增疾病中RNA致病机制的复杂性。
Front Mol Neurosci. 2013 Dec 3;6:45. doi: 10.3389/fnmol.2013.00045.
4
Triplet repeats in transcripts: structural insights into RNA toxicity.转录本中的三核苷酸重复:对 RNA 毒性的结构见解。
Biol Chem. 2012 Nov;393(11):1299-315. doi: 10.1515/hsz-2012-0218.
5
Polyglutamine expansion diseases: failing to deliver.多聚谷氨酰胺扩增疾病:传递失败。
Trends Mol Med. 2005 Feb;11(2):64-70. doi: 10.1016/j.molmed.2004.12.002.
6
[Aggregation and toxicity of the proteins with polyQ repeats].[具有多聚谷氨酰胺重复序列的蛋白质的聚集与毒性]
Postepy Biochem. 2005;51(2):215-22.
7
Proteins Containing Expanded Polyglutamine Tracts and Neurodegenerative Disease.含有扩展型聚谷氨酰胺序列的蛋白质与神经退行性疾病
Biochemistry. 2017 Mar 7;56(9):1199-1217. doi: 10.1021/acs.biochem.6b00936. Epub 2017 Feb 21.
8
The pathogenic agent in Drosophila models of 'polyglutamine' diseases.果蝇“多聚谷氨酰胺”疾病模型中的病原体。
Hum Mol Genet. 2005 Apr 15;14(8):1041-8. doi: 10.1093/hmg/ddi096. Epub 2005 Mar 9.
9
Assessing a peptidylic inhibitor-based therapeutic approach that simultaneously suppresses polyglutamine RNA- and protein-mediated toxicities in patient cells and Drosophila.评估一种基于肽基抑制剂的治疗方法,该方法可同时抑制患者细胞和果蝇中聚谷氨酰胺RNA和蛋白质介导的毒性。
Dis Model Mech. 2016 Mar;9(3):321-34. doi: 10.1242/dmm.022350. Epub 2016 Feb 2.
10
Exploring the Potential of Small Molecule-Based Therapeutic Approaches for Targeting Trinucleotide Repeat Disorders.探索基于小分子的治疗方法在靶向三核苷酸重复序列疾病中的潜力。
Mol Neurobiol. 2020 Jan;57(1):566-584. doi: 10.1007/s12035-019-01724-4. Epub 2019 Aug 9.

引用本文的文献

1
Unraveling the intricate link between cell death and neuroinflammation using as a model.以……为模型揭示细胞死亡与神经炎症之间的复杂联系。 (你提供的原文“using as a model”中少了具体内容)
Front Cell Dev Biol. 2024 Oct 1;12:1479864. doi: 10.3389/fcell.2024.1479864. eCollection 2024.
2
Polyglutamine-expanded ATXN7 alters a specific epigenetic signature underlying photoreceptor identity gene expression in SCA7 mouse retinopathy.多聚谷氨酰胺扩展的 ATXN7 改变了 SCA7 小鼠视网膜病变中感光细胞身份基因表达的特定表观遗传特征。
J Biomed Sci. 2022 Dec 20;29(1):107. doi: 10.1186/s12929-022-00892-1.
3
Conditioned medium from BV2 microglial cells having polyleucine specifically alters startle response in mice.

本文引用的文献

1
RAN translation and frameshifting as translational challenges at simple repeats of human neurodegenerative disorders.在人类神经退行性疾病的简单重复序列处,RAN翻译和移码作为翻译挑战。
Nucleic Acids Res. 2014 Oct 29;42(19):11849-64. doi: 10.1093/nar/gku794. Epub 2014 Sep 12.
2
Oligonucleotide-based strategies to combat polyglutamine diseases.基于寡核苷酸的多聚谷氨酰胺疾病防治策略。
Nucleic Acids Res. 2014 Jun;42(11):6787-810. doi: 10.1093/nar/gku385. Epub 2014 May 21.
3
Immune dysregulation as a cause of autoinflammation in fragile X premutation carriers: link between FMRI CGG repeat number and decreased cytokine responses.
BV2 小胶质细胞的条件培养基特异性改变了小鼠的惊跳反应。
Sci Rep. 2022 Nov 4;12(1):18718. doi: 10.1038/s41598-022-23571-5.
4
Exogenous polyserine and polyleucine are toxic to recipient cells.外源性多丝氨酸和多亮氨酸对受体细胞有毒性。
Sci Rep. 2022 Jan 31;12(1):1685. doi: 10.1038/s41598-022-05720-y.
5
Autophagy in Spinocerebellar ataxia type 2, a dysregulated pathway, and a target for therapy.脊髓小脑性共济失调 2 型中的自噬作用,一种失调的途径,以及治疗的靶点。
Cell Death Dis. 2021 Nov 29;12(12):1117. doi: 10.1038/s41419-021-04404-1.
6
Oxidative Stress and Neurodegeneration: Interconnected Processes in PolyQ Diseases.氧化应激与神经退行性变:多聚谷氨酰胺疾病中的相互关联过程。
Antioxidants (Basel). 2021 Sep 13;10(9):1450. doi: 10.3390/antiox10091450.
7
Myotonic dystrophy type 1 as a major risk factor for severe COVID-19?1 型肌强直性营养不良是否为 COVID-19 重症的一个主要危险因素?
Acta Neurol Belg. 2021 Dec;121(6):1761-1765. doi: 10.1007/s13760-020-01514-z. Epub 2020 Oct 14.
8
Polyglutamine-containing microglia leads to disturbed differentiation and neurite retraction of neuron-like cells.含有多聚谷氨酰胺的小胶质细胞会导致类神经元细胞的分化紊乱和神经突回缩。
Heliyon. 2020 Sep 6;6(9):e04851. doi: 10.1016/j.heliyon.2020.e04851. eCollection 2020 Sep.
9
Universal RNAi Triggers for the Specific Inhibition of Mutant Huntingtin, Atrophin-1, Ataxin-3, and Ataxin-7 Expression.用于特异性抑制突变型亨廷顿蛋白、萎缩素-1、共济失调蛋白-3和共济失调蛋白-7表达的通用RNA干扰触发剂。
Mol Ther Nucleic Acids. 2020 Mar 6;19:562-571. doi: 10.1016/j.omtn.2019.12.012. Epub 2019 Dec 18.
10
Expression of Human Endogenous Retrovirus-K in Spinal and Bulbar Muscular Atrophy.人内源性逆转录病毒-K在脊髓延髓肌萎缩症中的表达
Front Neurol. 2019 Sep 4;10:968. doi: 10.3389/fneur.2019.00968. eCollection 2019.
免疫失调作为脆性X前突变携带者自身炎症的一个原因:FMR1基因CGG重复序列数量与细胞因子反应降低之间的联系
PLoS One. 2014 Apr 9;9(4):e94475. doi: 10.1371/journal.pone.0094475. eCollection 2014.
4
Huntington disease: natural history, biomarkers and prospects for therapeutics.亨廷顿病:自然史、生物标志物和治疗前景。
Nat Rev Neurol. 2014 Apr;10(4):204-16. doi: 10.1038/nrneurol.2014.24. Epub 2014 Mar 11.
5
Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors.突变亨廷顿蛋白通过髓系细胞决定因子促进自主小胶质细胞的激活。
Nat Neurosci. 2014 Apr;17(4):513-21. doi: 10.1038/nn.3668. Epub 2014 Mar 2.
6
HTT-lowering reverses Huntington's disease immune dysfunction caused by NFκB pathway dysregulation.降低 HTT 可逆转 NFκB 通路失调引起的亨廷顿病免疫功能障碍。
Brain. 2014 Mar;137(Pt 3):819-33. doi: 10.1093/brain/awt355. Epub 2014 Jan 22.
7
Blood expression profiles of fragile X premutation carriers identify candidate genes involved in neurodegenerative and infertility phenotypes.脆性 X 前突变携带者的血液表达谱鉴定出与神经退行性和不孕表型相关的候选基因。
Neurobiol Dis. 2014 May;65:43-54. doi: 10.1016/j.nbd.2013.12.020. Epub 2014 Jan 10.
8
Intrajugular vein delivery of AAV9-RNAi prevents neuropathological changes and weight loss in Huntington's disease mice.经颈内静脉递送AAV9-RNAi可预防亨廷顿病小鼠的神经病理变化和体重减轻。
Mol Ther. 2014 Apr;22(4):797-810. doi: 10.1038/mt.2013.289. Epub 2014 Jan 6.
9
Inflammation in neurodegenerative diseases--an update.神经退行性疾病中的炎症——最新研究进展。
Immunology. 2014 Jun;142(2):151-66. doi: 10.1111/imm.12233.
10
Roles of the nucleolus in the CAG RNA-mediated toxicity.核仁在CAG RNA介导的毒性中的作用。
Biochim Biophys Acta. 2014 Jun;1842(6):779-84. doi: 10.1016/j.bbadis.2013.11.015. Epub 2013 Nov 20.